Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
Luigi Gennari, Daniela Merlotti, Ranuccio NutiDepartment of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Siena, ItalyAbstract: Selective estrogen receptor modulators (SERMs) represent a class with a growing number of compounds that act as either estrogen rec...
Guardado en:
Autores principales: | Luigi Gennari, Daniela Merlotti, Ranuccio Nuti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/710260fdbd414cfe956d013b4a9c7646 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011) -
Alta prevalencia de osteoporosis en mujeres mapuches postmenopáusicas asintomáticas
por: Ponce L,Lucía, et al.
Publicado: (2002) -
Muscular strength measurements indicate bone mineral density loss in postmenopausal women
por: Zhou Z, et al.
Publicado: (2013) -
Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
por: Tao Y, et al.
Publicado: (2021) -
Association between Bone Mineral Density and Metabolic Syndrome among Reproductive, Menopausal Transition, and Postmenopausal Women
por: Rogelio Salas, et al.
Publicado: (2021)